Fox Hill Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.63M Sell
9,385
-19
-0.2% -$19.3K 4.15% 4
2025
Q4
$10.1M Sell
9,404
-44
-0.5% -$42.1K 4.7% 4
2025
Q3
$7.21M Buy
9,448
+191
+2% +$142K 3.37% 5
2025
Q2
$7.22M Sell
9,257
-72
-0.8% -$55.9K 3.71% 5
2025
Q1
$7.7M Sell
9,329
-52
-0.6% -$43.3K 4.55% 3
2024
Q4
$7.24M Sell
9,381
-969
-9% -$802K 4.1% 4
2024
Q3
$9.17M Sell
10,350
-296
-3% -$266K 5.05% 3
2024
Q2
$9.64M Buy
10,646
+106
+1% +$84.8K 5.9% 3
2024
Q1
$8.2M Buy
10,540
+492
+5% +$350K 5.52% 2
2023
Q4
$5.86M Buy
+10,048
New +$5.87M 4.49% 3

Other funds holding LLY

Fox Hill Wealth Management's LLY Position: Q1 2026 in Review

Fox Hill Wealth Management reduced its Eli Lilly (LLY) stake by 0.2% in Q1 2026, selling an estimated $19.3K and leaving 9,385 shares worth $8.63M. The position accounts for 4.15% of the portfolio, ranked #4.

Fox Hill Wealth Management first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $10.1M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Fox Hill Wealth Management held 9,385 shares of Eli Lilly worth $8.63M as of Q1 2026.
  • Fox Hill Wealth Management sold 19 Eli Lilly shares in Q1 2026, an estimated $19.3K.
  • Eli Lilly made up 4.15% of Fox Hill Wealth Management's portfolio in Q1 2026, its #4 holding.
  • Fox Hill Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Fox Hill Wealth Management's Eli Lilly position peaked at $10.1M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Fox Hill Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.